These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10565903)

  • 1. Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.
    Redding SW; Zellars RC; Kirkpatrick WR; McAtee RK; Caceres MA; Fothergill AW; Lopez-Ribot JL; Bailey CW; Rinaldi MG; Patterson TF
    J Clin Microbiol; 1999 Dec; 37(12):3896-900. PubMed ID: 10565903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oropharyngeal candidiasis caused by non-albicans yeast in patients receiving external beam radiotherapy for head-and-neck cancer.
    Dahiya MC; Redding SW; Dahiya RS; Eng TY; Kirkpatrick WR; Coco BJ; Sadkowski LC; Fothergill AW; Waite A; Rinaldi MG; Patterson TF; Thomas CR
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):79-83. PubMed ID: 12909218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluconazole susceptibility and genotypic heterogeneity of oral Candida albicans colonies from the patients with cancer receiving chemotherapy in China.
    Sun J; Qi C; Lafleur MD; Qi QG
    Int J Oral Sci; 2009 Sep; 1(3):156-62. PubMed ID: 20695081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
    Sobel JD; Ohmit SE; Schuman P; Klein RS; Mayer K; Duerr A; Vazquez JA; Rampalo A;
    J Infect Dis; 2001 Jan; 183(2):286-93. PubMed ID: 11204125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oropharyngeal candidiasis in head and neck cancer patients in Iran: Species identification, antifungal susceptibility and pathogenic characterization.
    Jahanshiri Z; Manifar S; Moosa H; Asghari-Paskiabi F; Mahmoodzadeh H; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Jun; 28(2):361-366. PubMed ID: 29602636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymptomatic oral yeast carriage and antifungal susceptibility profile of HIV-infected patients in Kunming, Yunnan Province of China.
    Li YY; Chen WY; Li X; Li HB; Li HQ; Wang L; He L; Yang XP; Wang XC; Huang YL; Yao YG
    BMC Infect Dis; 2013 Jan; 13():46. PubMed ID: 23356471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candida dubliniensis in radiation-induced oropharyngeal candidiasis.
    Redding SW; Bailey CW; Lopez-Ribot JL; Kirkpatrick WR; Fothergill AW; Rinaldi MG; Patterson TF
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Jun; 91(6):659-62. PubMed ID: 11402278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-sectional study of the susceptibility of Candida isolates to antifungal drugs and in vitro-in vivo correlation in HIV-infected patients.
    Chavanet P; Lopez J; Grappin M; Bonnin A; Duong M; Waldner A; Buisson M; Camerlynck P; Portier H
    AIDS; 1994 Jul; 8(7):945-50. PubMed ID: 7946104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole susceptibility of Candida isolates from oropharyngeal candidosis.
    Dannaoui E; Lacoste V; Prat C; Piens MA
    Mycoses; 1997 Nov; 40(7-8):279-82. PubMed ID: 9476510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antifungal susceptibility testing of commensal and pathogenic clinical isolates of oral Candida].
    Zhao M; Zhou ZT
    Shanghai Kou Qiang Yi Xue; 2006 Apr; 15(2):218-20. PubMed ID: 16685371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of fluconazole as antimycotic prophylaxis in radiotherapy of patients with head and neck tumors].
    Mücke R; Kaben U; Libera T; Knauerhase H; Ziegler PG; Hamann D; Strietzel M
    Mycoses; 1997; 40 Suppl 1():53-5. PubMed ID: 9417514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral Candida isolates and fluconazole susceptibility patterns in older Mexican women.
    Benito-Cruz B; Aranda-Romo S; López-Esqueda FJ; de la Rosa-García E; Rosas-Hernández R; Sánchez-Vargas LO
    Arch Gerontol Geriatr; 2016; 65():204-10. PubMed ID: 27088219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Random amplification of polymorphic DNA and microsatellite genotyping of pre- and posttreatment isolates of Candida spp. from human immunodeficiency virus-infected patients on different fluconazole regimens.
    Metzgar D; van Belkum A; Field D; Haubrich R; Wills C
    J Clin Microbiol; 1998 Aug; 36(8):2308-13. PubMed ID: 9666011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
    Bulacio L; Paz M; Ramadán S; Ramos L; Pairoba C; Sortino M; Escovich L; López C
    J Mycol Med; 2012 Dec; 22(4):348-53. PubMed ID: 23518170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Belazi M; Velegraki A; Koussidou-Eremondi T; Andreadis D; Hini S; Arsenis G; Eliopoulou C; Destouni E; Antoniades D
    Oral Microbiol Immunol; 2004 Dec; 19(6):347-51. PubMed ID: 15491459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole susceptibility and strain variation of Candida albicans isolates from HIV-infected patients with oropharyngeal candidosis.
    Barchiesi F; Arzeni D; Del Prete MS; Sinicco A; Falconi Di Francesco L; Pasticci MB; Lamura L; Nuzzo MM; Burzacchini F; Coppola S; Chiodo F; Scalise G
    J Antimicrob Chemother; 1998 May; 41(5):541-8. PubMed ID: 9630407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
    Moris DV; Melhem MSC; Martins MA; Souza LR; Kacew S; Szeszs MW; Carvalho LR; Pimenta-Rodrigues MV; Berghs HAM; Mendes RP
    J Med Microbiol; 2012 Dec; 61(Pt 12):1758-1765. PubMed ID: 22956748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Candida isolates among HIV-infected subjects in Nigeria.
    Nweze EI; Ogbonnaya UL
    J Microbiol Immunol Infect; 2011 Jun; 44(3):172-7. PubMed ID: 21524610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
    Kirkpatrick WR; Revankar SG; Mcatee RK; Lopez-Ribot JL; Fothergill AW; McCarthy DI; Sanche SE; Cantu RA; Rinaldi MG; Patterson TF
    J Clin Microbiol; 1998 Oct; 36(10):3007-12. PubMed ID: 9738058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.